Advances in Supportive Care in Cancer during Pandemics and Natural Disasters: COVID-19 and Beyond
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 413
Special Issue Editor
Interests: clinical and scientific research activities dedicated to promotion and personalization of supportive care in cancer and improving patient’s quality of life
Special Issue Information
Dear Colleagues,
Natural disasters are becoming more frequent and severe, placing additional strains on supportive care services among cancer patients. Although supportive and palliative care are considered essential components of disaster planning and response, there are gaps in understandings about their real-life applications.
Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019 (COVID-19)), resulting in unprecedented challenges. Both supportive and palliative care are essential components of cancer treatment, which seek to prevent and manage chemotherapy complications, such as febrile neutropenia, anaemia, thrombocytopenia/bleeding, thromboembolic events and nausea/vomiting, all of which are common causes of hospitalisation. These adverse events are an essential consideration under routine patient management, but particularly so during a pandemic—a setting in which clinicians aim to minimise patients' risk of infection and need for hospital visits.
Dr. Raffaele Giusti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- supportive care
- palliative care
- cancer
- COVID-19
- vaccination
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
